Safety and efficacy of baricitinib through 128 weeks in an open-label, long-term extension study in patients with rheumatoid arthritis

Authors
Publication date
1 September 2015
Publisher
German Medical Science GMS Publishing House; Düsseldorf
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      German Medical Science

      redirect
      oaioai:oai-gms.dimdi.de:GM15dgrh0...
      Last time updated on 09/07/2019